Windlas Biotech Ltd
NSE:WINDLAS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
China Tower Corp Ltd
HKEX:788
|
CN |
Windlas Biotech Ltd
Total Liabilities
Windlas Biotech Ltd
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Windlas Biotech Ltd
NSE:WINDLAS
|
Total Liabilities
₹2.5B
|
CAGR 3-Years
38%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Divi's Laboratories Ltd
NSE:DIVISLAB
|
Total Liabilities
₹27.4B
|
CAGR 3-Years
26%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Syngene International Ltd
NSE:SYNGENE
|
Total Liabilities
₹18.1B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
14%
|
|
|
O
|
Onesource Specialty Pharma Ltd
NSE:ONESOURCE
|
Total Liabilities
₹16.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sai Life Sciences Ltd
NSE:SAILIFE
|
Total Liabilities
₹10.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Anthem Biosciences Ltd
NSE:ANTHEM
|
Total Liabilities
₹4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Windlas Biotech Ltd
Glance View
Windlas Biotech Ltd. operates as a contract development and manufacturing organization (CDMO). The firm provides a range of contract development and manufacturing organization (CDMO) services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics. Its therapeutic categories, such as, anti-diabetic, cardiovascular, neuropsychiatry and respiratory therapies. The Company’s service capabilities include formulation development, technology scale-up and full-scale commercial manufacturing. The company has capabilities for both solid and liquid pharmaceutical dosage forms. The Company’s market its own manufactured nutraceutical, pharmaceutical and ayurvedic products to serve the semi-urban and rural communities. The company also has a salesforce and distribution network spread across over 14 states. The Company’s manufacturing facilities are located at Dehradun in Uttarakhand.
See Also
What is Windlas Biotech Ltd's Total Liabilities?
Total Liabilities
2.5B
INR
Based on the financial report for Mar 31, 2025, Windlas Biotech Ltd's Total Liabilities amounts to 2.5B INR.
What is Windlas Biotech Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
15%
Over the last year, the Total Liabilities growth was 44%. The average annual Total Liabilities growth rates for Windlas Biotech Ltd have been 38% over the past three years , 15% over the past five years .
